FOSL1 and breast cancer: In a mouse breast cancer model, miR-19a induced the switch from the immunosuppressive M2 to the pro-inflammatory M1 TAM phenotype by targeting Fos-related antigen-1 (Fra-1) and the Fra-1/STAT3 signaling pathway and controlled tumor growth and invasion [13].